FAVEZELIMAB
UNII H1396W7D1H

Substance Identification & Data

This profile provides standardized clinical and technical data for Favezelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H1396W7D1H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2231068-83-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H1396W7D1H

CAS Registry Number

2231068-83-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FAVEZELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C142077

National Cancer Institute reference terminology for clinical and research data.

INN ID

11179

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-177

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Favezelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FAVEZELIMAB

Common Names & Synonyms

ANTI-LAG3 MONOCLONAL ANTIBODY MK-4280

FAVEZELIMAB [INN]

FAVEZELIMAB [USAN]

FAVEZELIMAB [WHO-DD]

IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3) (HUMAN-MUS MUSCULUS MONOCLONAL C88 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C88 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV1-58*01 (85.6%) -(IGHD) -IGHJ1*01 (91.7%)) (8.8.12) (1-119) -HOMO SAPIENS IGHG4*01 (CH1 (120-217), HINGE 1-12 (218-229), CH2 (230-339), CH3 (340-444), CHS (445-446)) (120-446)), (133- 218')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'- 218') (V-KAPPA (HOMO SAPIENS IGKV2D-29*01 (82.0%) -IGKJ4*01 (100%))(10.3.9) (1'-111') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

MAVEZELIMAB